Predictive Genetic Testing And Consumer Genomics Market Size, Share & Trends Analysis Report By Test, By Application, By Setting (DTC, Professional), By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Genetic Testing And Consumer Genomics Market Growth & Trends
The global predictive genetic testing and consumer genomics market size is expected treach USD 9.51 billion by 2030, registering a CAGR of 12.3% from 2025 t2030, according ta new report by Grand View Research, Inc. Factors influencing the market progression include growing awareness about utilization of genetic tests that aid in prediction of gene susceptibility tdisease development prior tsymptoms. Moreover, rise in sales of these products owing tgrowing inclination of physicians is driving the market.
Introduction of novel platforms in next-generation sequencing technology aids in enhancing the accuracy of predictive genetic and consumer genomics kits. Market participants are engaged in implementing novel protocols tlaunch products that require minimal technical assistance and provide optimal customer satisfaction.
Pharmaceutical firms are engaged in several agreement models with genomic vendors for the release of novel therapeutics based on patient’s phenotypic and genotypic information. For instance, in July 2018, GlaxoSmithKline plc purchased 23andMe’s customer data tdevelop a new drug, thus promoting patient-centered healthcare.
Predictive Genetic Testing And Consumer Genomics Market Report Highlights
Genetic Testing And Consumer Genomics Market Growth & Trends
The global predictive genetic testing and consumer genomics market size is expected treach USD 9.51 billion by 2030, registering a CAGR of 12.3% from 2025 t2030, according ta new report by Grand View Research, Inc. Factors influencing the market progression include growing awareness about utilization of genetic tests that aid in prediction of gene susceptibility tdisease development prior tsymptoms. Moreover, rise in sales of these products owing tgrowing inclination of physicians is driving the market.
Introduction of novel platforms in next-generation sequencing technology aids in enhancing the accuracy of predictive genetic and consumer genomics kits. Market participants are engaged in implementing novel protocols tlaunch products that require minimal technical assistance and provide optimal customer satisfaction.
Pharmaceutical firms are engaged in several agreement models with genomic vendors for the release of novel therapeutics based on patient’s phenotypic and genotypic information. For instance, in July 2018, GlaxoSmithKline plc purchased 23andMe’s customer data tdevelop a new drug, thus promoting patient-centered healthcare.
Predictive Genetic Testing And Consumer Genomics Market Report Highlights
- The predictive testing segment accounted for a significant market revenue share in 2024. This testing is expected twitness a steady demand in the coming years on account of rising incidences of genetic disorders among the global population and increasing focus on genetic counseling services.
- The breast & ovarian cancer segment accounted for the largest revenue share in 2024 and is expected tmaintain its leading position during the forecast period.
- The DTC segment accounted for a dominant revenue share in the market in 2024, as these tests are available at economical costs tconsumers.
- North America led the market in 2024, accounting for a 45.9% global revenue share. The extensive presence of key players undertaking initiatives tenhance their consumer genomics & predictive genetic testing offerings is anticipated tpropel regional market growth.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test
1.2.2. Application
1.2.3. Setting
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.2. Market Restraints Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
CHAPTER 4. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: TEST BUSINESS ANALYSIS
4.1. Test Market Share, 2024 & 2030
4.2. Test Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, By Test, 2018 to 2030 (USD Million)
4.4. Predictive Testing
4.4.1. Predictive Testing Market, 2018 - 2030 (USD Million)
4.4.2. Genetic Susceptibility Test
4.4.2.1. Genetic Susceptibility Test Market, 2018 - 2030 (USD Million)
4.4.3. Predictive Diagnostics
4.4.3.1. Predictive Diagnostics Market, 2018 - 2030 (USD Million)
4.4.4. Population Screening
4.4.4.1. Population Screening Market, 2018 - 2030 (USD Million)
4.5. Consumer Genomics
4.5.1. Consumer Genomics Market, 2018 - 2030 (USD Million)
4.6. Wellness Genomics
4.6.1. Wellness Genomics Market, 2018 - 2030 (USD Million)
4.6.2. Nutria Genetics
4.6.2.1. Nutria Genetics Market, 2018 - 2030 (USD Million)
4.6.3. Skin & Metabolism Genetics
4.6.3.1. Skin & Metabolism Genetics Market, 2018 - 2030 (USD Million)
4.6.4. Others
4.6.4.1. Other Tests Market, 2018 - 2030 (USD Million)
CHAPTER 5. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, By Application, 2018 to 2030 (USD Million)
5.4. Breast & Ovarian Cancer
5.4.1. Breast & Ovarian Cancer Market, 2018 - 2030 (USD Million)
5.5. Cardiovascular Screening
5.5.1. Cardiovascular Screening Market, 2018 - 2030 (USD Million)
5.6. Diabetic Screening & Monitoring
5.6.1. Diabetic Screening & Monitoring Market, 2018 - 2030 (USD Million)
5.7. Colon Cancer
5.7.1. Colon Cancer Market, 2018 - 2030 (USD Million)
5.8. Parkinsonism/Alzheimer’s Disease
5.8.1. Parkinsonism/Alzheimer’s Disease Market, 2018 - 2030 (USD Million)
5.9. Urologic Screening/ Prostate Cancer Screening
5.9.1. Urologic Screening/ Prostate Cancer Screening Market, 2018 - 2030 (USD Million)
5.10. Orthopedic & Musculoskeletal
5.10.1. Orthopedic & Musculoskeletal Market, 2018 - 2030 (USD Million)
5.11. Other Cancer Screening
5.11.1. Other Cancer Screening Market, 2018 - 2030 (USD Million)
5.12. Other Diseases
5.12.1. Other Diseases Market, 2018 - 2030 (USD Million)
CHAPTER 6. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: SETTING ESTIMATES & TREND ANALYSIS
6.1. Setting Market Share, 2024 & 2030
6.2. Setting Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, By Setting, 2018 to 2030 (USD Million)
6.4. DTC
6.4.1. DTC Market, 2018 - 2030 (USD Million)
6.5. Professional
6.5.1. Professional Market, 2018 - 2030 (USD Million)
CHAPTER 7. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. UK Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. Germany Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. China Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Japan
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. Japan Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Singapore
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. Singapore Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. Australia Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. 23andMe, Inc.
8.5.1.1. Participant’s Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Recent Developments/ Strategic Initiatives
8.5.2. Myriad Genetics, Inc.
8.5.2.1. Participant’s Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Recent Developments/ Strategic Initiatives
8.5.3. F. Hoffmann-La Roche Ltd
8.5.3.1. Participant’s Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Recent Developments/ Strategic Initiatives
8.5.4. Abbott
8.5.4.1. Participant’s Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Recent Developments/ Strategic Initiatives
8.5.5. Agilent Technologies, Inc.
8.5.5.1. Participant’s Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Recent Developments/ Strategic Initiatives
8.5.6. Thermo Fisher Scientific Inc.
8.5.6.1. Participant’s Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Recent Developments/ Strategic Initiatives
8.5.7. BGI
8.5.7.1. Participant’s Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Recent Developments/ Strategic Initiatives
8.5.8. Bio-Rad Laboratories, Inc.
8.5.8.1. Participant’s Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Recent Developments/ Strategic Initiatives
8.5.9. Illumina, Inc.
8.5.9.1. Participant’s Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Recent Developments/ Strategic Initiatives
8.5.10. ARUP Laboratories
8.5.10.1. Participant’s Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test
1.2.2. Application
1.2.3. Setting
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.2. Market Restraints Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
CHAPTER 4. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: TEST BUSINESS ANALYSIS
4.1. Test Market Share, 2024 & 2030
4.2. Test Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, By Test, 2018 to 2030 (USD Million)
4.4. Predictive Testing
4.4.1. Predictive Testing Market, 2018 - 2030 (USD Million)
4.4.2. Genetic Susceptibility Test
4.4.2.1. Genetic Susceptibility Test Market, 2018 - 2030 (USD Million)
4.4.3. Predictive Diagnostics
4.4.3.1. Predictive Diagnostics Market, 2018 - 2030 (USD Million)
4.4.4. Population Screening
4.4.4.1. Population Screening Market, 2018 - 2030 (USD Million)
4.5. Consumer Genomics
4.5.1. Consumer Genomics Market, 2018 - 2030 (USD Million)
4.6. Wellness Genomics
4.6.1. Wellness Genomics Market, 2018 - 2030 (USD Million)
4.6.2. Nutria Genetics
4.6.2.1. Nutria Genetics Market, 2018 - 2030 (USD Million)
4.6.3. Skin & Metabolism Genetics
4.6.3.1. Skin & Metabolism Genetics Market, 2018 - 2030 (USD Million)
4.6.4. Others
4.6.4.1. Other Tests Market, 2018 - 2030 (USD Million)
CHAPTER 5. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, By Application, 2018 to 2030 (USD Million)
5.4. Breast & Ovarian Cancer
5.4.1. Breast & Ovarian Cancer Market, 2018 - 2030 (USD Million)
5.5. Cardiovascular Screening
5.5.1. Cardiovascular Screening Market, 2018 - 2030 (USD Million)
5.6. Diabetic Screening & Monitoring
5.6.1. Diabetic Screening & Monitoring Market, 2018 - 2030 (USD Million)
5.7. Colon Cancer
5.7.1. Colon Cancer Market, 2018 - 2030 (USD Million)
5.8. Parkinsonism/Alzheimer’s Disease
5.8.1. Parkinsonism/Alzheimer’s Disease Market, 2018 - 2030 (USD Million)
5.9. Urologic Screening/ Prostate Cancer Screening
5.9.1. Urologic Screening/ Prostate Cancer Screening Market, 2018 - 2030 (USD Million)
5.10. Orthopedic & Musculoskeletal
5.10.1. Orthopedic & Musculoskeletal Market, 2018 - 2030 (USD Million)
5.11. Other Cancer Screening
5.11.1. Other Cancer Screening Market, 2018 - 2030 (USD Million)
5.12. Other Diseases
5.12.1. Other Diseases Market, 2018 - 2030 (USD Million)
CHAPTER 6. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: SETTING ESTIMATES & TREND ANALYSIS
6.1. Setting Market Share, 2024 & 2030
6.2. Setting Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, By Setting, 2018 to 2030 (USD Million)
6.4. DTC
6.4.1. DTC Market, 2018 - 2030 (USD Million)
6.5. Professional
6.5.1. Professional Market, 2018 - 2030 (USD Million)
CHAPTER 7. PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. UK Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. Germany Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. China Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Japan
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. Japan Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Singapore
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. Singapore Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. Australia Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa Predictive Genetic Testing and Consumer Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. 23andMe, Inc.
8.5.1.1. Participant’s Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Recent Developments/ Strategic Initiatives
8.5.2. Myriad Genetics, Inc.
8.5.2.1. Participant’s Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Recent Developments/ Strategic Initiatives
8.5.3. F. Hoffmann-La Roche Ltd
8.5.3.1. Participant’s Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Recent Developments/ Strategic Initiatives
8.5.4. Abbott
8.5.4.1. Participant’s Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Recent Developments/ Strategic Initiatives
8.5.5. Agilent Technologies, Inc.
8.5.5.1. Participant’s Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Recent Developments/ Strategic Initiatives
8.5.6. Thermo Fisher Scientific Inc.
8.5.6.1. Participant’s Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Recent Developments/ Strategic Initiatives
8.5.7. BGI
8.5.7.1. Participant’s Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Recent Developments/ Strategic Initiatives
8.5.8. Bio-Rad Laboratories, Inc.
8.5.8.1. Participant’s Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Recent Developments/ Strategic Initiatives
8.5.9. Illumina, Inc.
8.5.9.1. Participant’s Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Recent Developments/ Strategic Initiatives
8.5.10. ARUP Laboratories
8.5.10.1. Participant’s Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Recent Developments/ Strategic Initiatives
